方法：33例晚期乳腺癌患者。
Methods: 33 patients with advanced breast cancer were studied.
方法对54例晚期乳腺癌患者进行观察。
Methods The clinical data of 54 cases with advanced breast cancer were analyzed retrospectively.
结论：单药泰索帝治疗晚期乳腺癌疗效肯定。
Conclusion: Taxotere as a single agent therapy is effective.
目的探讨新辅助化疗在晚期乳腺癌治疗中的效果。
Objective To study the clinical effect of neoadjuvant chemotherapy on advanced breast cancer.
目的探讨CAP治疗晚期乳腺癌的疗效和安全性。
ObjectiveTo explore the efficacy and safety of CAP regimen in the treatment of advanced breast cancer.
目的评价紫杉醇联合顺铂对晚期乳腺癌的治疗作用。
Objective To evaluate the effect of paclitaxel combined DDP on advanced breast cancer.
患有晚期乳腺癌的妇女日常服用阿司匹林是否有益？
Would women who suffered from a later stage of breast cancer benefit from daily aspirin?
研究人员未发现饮用绿茶对晚期乳腺癌患者有显著疗效。
The researchers did't see these benefits for women with later-stage TUMOR.
目的研究新辅助化疗在中晚期乳腺癌保乳治疗中的应用价值。
Objective To study the value of pre-operative chemotherapy combined with breast conservation surgery for the treatment of middle-advanced breast cancer.
因此，让我们回到抗癌药物上来，例如，晚期乳腺癌的药物-贝伐株单抗。
So if we go back, for example, to the drug bevacizumab in connection with advanced breast cancer...
目前，医学教科书估计的晚期乳腺癌中位生存期为2年至3年。
Currently, medical textbooks estimate the median survival for advanced breast cancer to be 2 to 3 years.
目的研究紫杉醇治疗阿霉素耐药的晚期乳腺癌的疗效和耐受性。
To study the efficacy and tolerance of paclitaxel therapy for metastatic breast cancer with adriamycin resistance.
前言： 目的：探讨新辅助化疗在局部晚期乳腺癌治疗中的应用。
Objective: To evaluate the effect of neoadjuvant chemotherapy in the treatment of locally advanced breast cancer.
目的评价紫杉醇联合卡培他滨治疗晚期乳腺癌的疗效和毒副作用。
Objective to evaluate the therapeutic effects and toxicities of paclitaxel and capecitabine combination regimen in the treatment of advanced breast cancer.
目的分析单药紫杉醇治疗晚期乳腺癌剂量强度与疗效和毒性的关系。
Objective to evaluate the relation of dose intensity and efficacy, toxicity in advanced breast cancer treated with paclitaxel as a single agent.
目的观察弗隆和氨鲁米特治疗绝经后晚期乳腺癌的疗效和不良反应。
Objective: to compare the response and adverse reactions of aminoglutethimide with that of femara, an oral aromatase inhibitor, in postmenopausal women with advanced breast cancer.
方法：将60例晚期乳腺癌患者按教字表法随机分为2组，各30例。
Methods: 60 cases of LSMC were allocated to 2 groups (each group 30 cases) randomly.
单因素分析表明：临床分期、肿瘤大小是局部晚期乳腺癌的生存指标。
Univariate analysis found that the size of tumor, TNM stage were related to survival rates.
目的：观察国产多烯紫杉醇联合顺铂治疗晚期乳腺癌的疗效及毒副反应。
Objective: to observe the effects and toxicity of docetaxel plus DDP in treatment of advanced breast cancer.
目的比较CAF方案和CAP方案治疗晚期乳腺癌的疗效以及毒性反应。
Objective to compare the efficacy and toxicity of regimen CAF with regimen CAP.
方法：回顾性分析32例局部晚期乳腺癌患者进行新辅助化疗的临床资料。
Methods: 32 patients with locally advanced breast cancer treated by neoadjuvant chemotherapy were reviewed retrospectively.
目的比较紫杉醇加卡铂与紫杉醇加顺铂治疗晚期乳腺癌的疗效和不良反应。
Objective to evaluate and compare the efficacy and toxicity of paclitaxel plus carboplatin and paclitaxel plus cisplatin for the treatment of advanced breast cancer.
目的评价CEF方案新辅助化疗治疗局部晚期乳腺癌的临床疗效和毒性反应。
Objective to evaluate the clinical efficacy and toxicity of CEF as the neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer (LABC).
目的：观察以米托蒽醌为主的联合化疗治疗晚期乳腺癌的近期疗效与毒性反应。
Objective: to evaluate the effect and side effect of mitoxantrone combination chemotherapy for advanced breast cancer.
结论PT X为主的联合化疗方案治疗晚期乳腺癌疗效确切，不良反应可耐受。
Conclusion PTX treats the breast cancer of later period with the union chemotherapy scheme is effective, the poisonous side reaction can be tolerable.
结论：异基因非清髓性外周血干细胞移植可选择性地应用于晚期乳腺癌的治疗。
Conclusion: Allogeneic peripheral blood stem cell non-myeloablative transplantation can be selectively used in the treatment of metastasis breast cancer.
目的观察吉西他滨联合卡培他滨治疗蒽环类耐药性晚期乳腺癌的疗效与毒性反应。
Objective To observe the results of gemcitabine combined with capecitabine on anthracycline-resistant breast cancer.
目的探讨紫杉醇（PTX）为主的联合化疗方案治疗晚期乳腺癌的疗效及安全性。
Objective To explore paclitaxel(PTX) union chemotherapy curative effect and security for breast cancer of later period.
目的探讨紫杉醇（PTX）为主的联合化疗方案治疗晚期乳腺癌的疗效及安全性。
Objective To explore paclitaxel(PTX) union chemotherapy curative effect and security for breast cancer of later period.
应用推荐